Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H48N6O10 |
Molecular Weight | 592.6828 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O
InChI
InChIKey=IYDYFVUFSPQPPV-PEXOCOHZSA-N
InChI=1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1
Molecular Formula | C25H48N6O10 |
Molecular Weight | 592.6828 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:40:40 UTC 2023
by
admin
on
Sat Dec 16 01:40:40 UTC 2023
|
Record UNII |
LYO9XZ250J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID001031303
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
LYO9XZ250J
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
5287
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
9522
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
100000175065
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
Plazomicin
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
2049549
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
LYO9XZ250J
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
YY-39
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
1154757-24-0
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
m12109
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
C174680
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
CHEMBL1650559
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
Plazomicin
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
42613186
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY | |||
|
DB12615
Created by
admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR | |||
|
EXCRETED UNCHANGED |
Following a single IV dose of 15 mg/kg radiolabeled plazomicin, approximately 97.5% of the dose was recovered in the urine as unchanged plazomicin.
URINE
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR | |||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||